Mesothelioma Surgery can be applied to patients that have been diagnosed with an early-stage of mesothelioma. All or most of the tumour(s) can be removed by this method. This may include the removal of one or more lymph nodes, or the mesothelial tissue lining the affected lung or other organs.
In many cases, a multimodal approach is highly recommended by mesothelioma specialists. This approach uses a combination of the three type of the standard mesothelioma treatment. This multimodal approach has shown to be more effective than any of these treatment used alone. In recent years, an increase in the life expectancy of peritoneal mesothelioma patient has been experienced as a result of the combination of hyperthermic intraperitoneal chemotherapy (HIPEC) and surgery.
In multimodal treatment, a primary therapy is used in combination with a helper treatment used before or after the primary treatment, namely neoadjuvant therapy and adjuvant treatment respectively. A multimodal approach may comprise of the following:
- Primary Treatment: The removal of a tumour through surgery
- Neoadjuvant Therapy: Shrinking of tumour size by radiation
- Adjuvant Therapy: killing of remaining cells after surgery via chemotherapy